BioCentury
ARTICLE | Company News

Immune Network, Meditech Pharmaceuticals Inc. deal

October 30, 2000 8:00 AM UTC

IMM exercised its option to purchase 3.3 million shares of MDCH (see BioCentury, Feb. 7). The companies also agreed in principle to license terms covering international sales of MDCH products. ...